Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

586 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry.
Ghadri JR, Cammann VL, Jurisic S, Seifert B, Napp LC, Diekmann J, Bataiosu DR, D'Ascenzo F, Ding KJ, Sarcon A, Kazemian E, Birri T, Ruschitzka F, Lüscher TF, Templin C; InterTAK co-investigators. Ghadri JR, et al. Eur J Heart Fail. 2017 Aug;19(8):1036-1042. doi: 10.1002/ejhf.683. Epub 2016 Dec 7. Eur J Heart Fail. 2017. PMID: 27928880 Free article. Clinical Trial.
Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis.
Iannaccone M, Quadri G, Taha S, D'Ascenzo F, Montefusco A, Omede' P, Jang IK, Niccoli G, Souteyrand G, Yundai C, Toutouzas K, Benedetto S, Barbero U, Annone U, Lonni E, Imori Y, Biondi-Zoccai G, Templin C, Moretti C, Luscher TF, Gaita F. Iannaccone M, et al. Eur Heart J Cardiovasc Imaging. 2016 Oct;17(10):1128-37. doi: 10.1093/ehjci/jev283. Epub 2015 Oct 27. Eur Heart J Cardiovasc Imaging. 2016. PMID: 26508517 Review.
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study).
Biscaglia S, Ugo F, Ielasi A, Secco GG, Durante A, D'Ascenzo F, Cerrato E, Balghith M, Pasquetto G, Penzo C, Fineschi M, Bonechi F, Templin C, Menozzi M, Aquilina M, Rognoni A, Capasso P, Di Mario C, Brugaletta S, Campo G. Biscaglia S, et al. Int J Cardiol. 2016 Apr 1;208:40-5. doi: 10.1016/j.ijcard.2016.01.202. Epub 2016 Jan 21. Int J Cardiol. 2016. PMID: 26826788
Provisional vs. two-stent technique for unprotected left main coronary artery disease after ten years follow up: A propensity matched analysis.
D'Ascenzo F, Iannaccone M, Giordana F, Chieffo A, Connor SO, Napp LC, Chandran S, de la Torre Hernández JM, Chen SL, Varbella F, Omedè P, Taha S, Meliga E, Kawamoto H, Montefusco A, Chong M, Garot P, Sin L, Gasparetto V, Abdirashid M, Cerrato E, Biondi-Zoccai G, Gaita F, Escaned J, Hiddick Smith D, Lefèvre T, Colombo A, Sheiban I, Moretti C. D'Ascenzo F, et al. Int J Cardiol. 2016 May 15;211:37-42. doi: 10.1016/j.ijcard.2016.02.136. Epub 2016 Mar 3. Int J Cardiol. 2016. PMID: 26970964
Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis.
Iannaccone M, D'Ascenzo F, Templin C, Omedè P, Montefusco A, Guagliumi G, Serruys PW, Di Mario C, Kochman J, Quadri G, Biondi-Zoccai G, Lüscher TF, Moretti C, D'amico M, Gaita F, Stone GW. Iannaccone M, et al. Eur Heart J Cardiovasc Imaging. 2017 Feb;18(2):159-166. doi: 10.1093/ehjci/jew070. Epub 2016 Apr 20. Eur Heart J Cardiovasc Imaging. 2017. PMID: 27099274 Review.
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated With Second-Generation Drug-Eluting Stents.
D'Ascenzo F, Moretti C, Bianco M, Bernardi A, Taha S, Cerrato E, Omedè P, Montefusco A, Frangieh AH, Lee CW, Campo G, Chieffo A, Quadri G, Pavani M, Zoccai GB, Gaita F, Park SJ, Colombo A, Templin C, Lüscher TF, Stone GW. D'Ascenzo F, et al. Am J Cardiol. 2016 Jun 1;117(11):1714-23. doi: 10.1016/j.amjcard.2016.03.005. Epub 2016 Mar 19. Am J Cardiol. 2016. PMID: 27134057 Review.
Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.
Jaguszewski M, Dörig M, Frangieh AH, Ghadri JR, Cammann VL, Diekmann J, Napp LC, D'Ascenzo F, Imori Y, Obeid S, Maier W, Lüscher TF, Templin C. Jaguszewski M, et al. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):E173-E182. doi: 10.1002/ccd.26617. Epub 2016 Jul 5. Catheter Cardiovasc Interv. 2016. PMID: 27377554
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry.
Imori Y, D'Ascenzo F, Gori T, Münzel T, Fabrizio U, Campo G, Cerrato E, Napp LC, Iannaccone M, Ghadri JR, Kazemian E, Binder RK, Jaguszewski M, Csordas A, Capasso P, Biscaglia S, Conrotto F, Varbella F, Garbo R, Gaita F, Erne P, Lüscher TF, Moretti C, Frangieh AH, Templin C. Imori Y, et al. Cardiol J. 2016;23(4):374-83. doi: 10.5603/CJ.a2016.0052. Epub 2016 Aug 12. Cardiol J. 2016. PMID: 27515481 Free article. Clinical Trial.
586 results